$NXPL

NextPlat Corp's subsidiary, PharmcoRx, plans to launch automated prescription dispensing via VendRx kiosks in select clinics. The service aims to improve patient adherence and pharmacy growth by providing onsite prescription pickup. Initial deployments are expected in Q4 2026, with wider rollout in 2027. PharmcoRx believes this will expand its reach and prescription base.

NextPlat Corp. (NXPL) opened a new PharmcoRx pharmacy in Jacksonville, FL, expanding its network to six locations. The pharmacy offers prescription services, 340B program support, and specialty care. The company recently acquired a pharmacy near Pensacola for $1.49M, aiming to diversify its services and reduce reliance on single channels.

NextPlat Corp (NXPL) filed an SEC Form 8-K — Other Events. Exhibit 99.1 NextPlat Completes Pensacola-Area Acquisition of Profitable Pharmacy, Accelerating Continued Healthcare Growth and Profitability Strategic Acquisition Enhances Pharmacy Diversification into Underserved Market, Supporting the Launch of New High-Value, High Margin Heal

NextPlat Corp (NXPL) completed the acquisition of a profitable pharmacy near Pensacola, Florida, for $1.49M. The pharmacy generated $5.6M in 2025 sales and is debt-free. NextPlat expects it to boost its PharmcoRx segment's growth and profitability. The company plans to integrate the pharmacy and expand its high-margin services in the region.

NextPlat Corp (NXPL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NextPlat Reports 21% Sequential Quarterly Revenue Growth, 87% Reduction in Quarterly Net Loss to $144,000 and Record Gross Margin of Approximately 40% Growth Momentum Continues Across the Business, Highlighted by Increased Higher-Margin 340B Healthcare Prescription V

NextPlat Corp (NASDAQ: NXPL) reported Q2 2026 results ended June 30. Revenue was about $11.9M, up 21% sequentially. Net loss fell 92% to about $144K. Gross margin reached a record ~40% (Healthcare segment ~46%). Contracted pharmacy revenue rose 136% to ~$2.2M. The company also said it plans a Pensacola-area pharmacy acquisition.

NextPlat Corp (NASDAQ: NXPL) issued a mid-year 2026 shareholder update on its turnaround and growth plans. The company cited record consolidated gross margin of 35% for the quarter ended March 31, 2026, over $11M cash, and no material long-term debt. It reported 39% gross margin in Healthcare Operations, 340B prescriptions up over 70% YoY, and added six new 340B contracts in Q2. It also announced an acquisition of an independent pharmacy near Pensacola.

NextPlat Corp (NXPL) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex_988389.htm EXHIBIT 10.1 MEMBERSHIP INTEREST PURCHASE AGREEMENT ex_988389.htm Exhibit 10.1 MEMBERSHIP INTEREST PURCHASE AGREEMENT by and among RON G. SCOTT, an individual and PROGRESSIVE CARE, LLC, a Nevada Limited Liability Company dated as of July 14 , 2026 Exhibits

NextPlat Corp (NASDAQ: NXPL) agreed to acquire an independent pharmacy near Pensacola, Florida for $1.5 million in cash and expects closing in Q4 2026. The pharmacy generated about $5.6 million in 2025 sales with ~19% retail margins. NextPlat says the deal adds about $5.6 million in profitable annual revenue and expands PharmcoRx’s 340B and contracted services.

NextPlat Corp (NXPL) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. nxpl20260528c_8k.htm false 0001058307 0001058307 2026-06-24 2026-06-24 0001058307 nxpl:CommonStockCustomMember 2026-06-24 2026-06-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES E